Latest News about RARE
Recent news which mentions RARE
The Latest Analyst Ratings for Ultragenyx Pharmaceutical
December 30, 2022
Tickers
RARE
From Benzinga
Analyst Expectations for Ultragenyx Pharmaceutical's Future
December 30, 2022
Tickers
RARE
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
November 09, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2022
November 03, 2022
From Benzinga
Earnings Scheduled For November 2, 2022
November 02, 2022
From Benzinga
9 Health Care Stocks Whale Activity In Today's Session
November 01, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
October 13, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
September 14, 2022
From Benzinga
From Benzinga
Cisco, Keysight Technologies And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
August 18, 2022
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2022
August 01, 2022
From Benzinga
From Benzinga
Earnings Scheduled For July 28, 2022
July 28, 2022
From Benzinga
From Benzinga
Ultragenyx Shares Tumble On Initial Efficacy Missing Expectations, This Analyst Sees 'Viable Path Forward"
July 19, 2022
Tickers
RARE
From Benzinga
From Benzinga
From Benzinga
Dow Surges 500 Points; Johnson & Johnson Lowers Guidance
July 19, 2022
From Benzinga
This Financial Services Stock Is Trading Higher By 50%, Here Are 40 Stocks Moving In Tuesday's Mid-Day Session
July 19, 2022
From Benzinga
From Benzinga
From Benzinga
Ultragenyx's Neurogenetic Disorder Candidate Shows Favorable Tolerability, Clinical Activity
July 19, 2022
Tickers
RARE
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.